Drugs / GB001 recombinant peptide spray
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05125211 | Aug → Nov 2022 | — | Zhejiang Echon Biopharm Limited | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GB001 recombinant peptide spray | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05125211 ↗ |
| Modality | Peptide | “GB001 recombinant peptide” NCT05125211 ↗ |
| Route | Oral | “administrated oral spray” NCT05125211 ↗ |